SERUM C-REACTIVE PROTEIN IN HYPERTENSIVE HEART FAILURE WITH AND WITHOUT ATRIAL FIBRILLATION: A CASE-COMPARATIVE STUDY

Authors

A.P. Duduyemi1, G.I. Olajide2, P.O. Inedu2, B.D. Elusiyan2, E.O. Yusuf2, A. Aje1, A.M. Adeoye1,3, A.A. Adebiyi1,3, O.O. Oladapo1,3, O.S Ogah1,2,3

Correspondents

Prof. O.S Ogah
Faculty of Clinical Sciences,
College of Medicine,
University of Ibadan,
Ibadan, Oyo State,
Nigeria.
Email: osogah56156@gmail.com

Affiliation of Authors

1. Cardiology Unit, Department of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria
2. Cardiomyopathies, Heart Failure and Atrial Fibrillation Research, Cardiology Unit, Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
3. Cardiology Unit, Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria

ABSTRACT

Background: Atrial fibrillation (AF) and hypertensive heart failure (HHF) frequently co-exist, causing increased morbidity and mortality. While inflammation is a recognized driver of AF in Western populations, there is a paucity of data regarding the role of c-reactive protein (CRP) in African participants with HHF and AF.

Aim: To compare the level of serum C-reactive protein in hypertensive heart failure patients with atrial fibrillation, those in sinus rhythm and apparently normal individuals.

Methods: This hospital-based cross-sectional comparative study involved 180 participants divided into three groups (n=60 each): HHF with AF, HHF without AF, and apparently healthy controls. Participants underwent clinical evaluation, 12-lead electrocardiography, transthoracic echocardiography, and high-sensitivity CRP (hs-CRP) analysis.

Results: The mean ages of HHF with AF, HHF without AF, and apparently healthy participants were 65.3 ± 9.9years, 66.7 ± 9.7 years, and 64.3 ± 10.5 years, respectively. The concentration of CRP was significantly higher in the HHF without AF compared to HF with AF and the apparently normal controls (p<0.001). CRP correlated positively with left ventricular internal diameters and volumes (p < 0.001), and inversely with ejection fraction (r = -0.279, p < 0.001). Multivariate regression identified left atrial diameter (OR 2.26, p = 0.02) and
ejection fraction (OR 4.02, p = 0.04) as independent predictors of AF, while CRP was not.

Conclusion: Serum CRP was not significantly elevated in HHF participantswith AF compared to those without AF. These findings may suggest that elevated CRP, a surrogate marker for inflammation, is not the primary pathophysiological pathway for AF in this population. However, results may have been influenced by confounding factors such as the use of guideline-directed medical treatment
for hypertension and HF.

Keyword: Hypertension, Heart failure, Inflammation, Atrial fibrillation, C-Reactive protein.

Scroll to Top